Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. PPH: which is better?

Bottom line

XLV vs PPH: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PPH (VanEck Pharmaceutical ETF) share a meaningful slice of their top holdings — about 43% by weight.

But XLV is far broader, holding 65 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.

XLV is cheaper at 0.08% vs 0.36% — a difference of $28 a year per $10,000 invested.

Over five years, PPH returned +11.3% a year vs +8.1% for XLV.

Updated Nov 19, 2026

XLV vs PPH side by side

XLVPPH
TypeETFETF
Fund familySPDR (State Street)VanEck
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.36%
Annual cost per $10k$8$36
10-yr cost on $10k (prospectus)$103$456
Max front loadNoneNone
12b-1 fee0.02%—
1-yr return+14.5%+21.9%
5-yr return (annualized)+8.1%+11.3%
10-yr return (annualized)+9.8%+6.7%
Best quarter+14.5%+16.5%
Worst quarter−12.7%−15.0%
Net assets (fund)$40.6B$879.5M
Number of holdings6526
Portfolio turnover2%3%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVPPHDifference
2025+14.5%+21.9%−7.4%
2024+2.5%+8.1%−5.6%
2023+2.0%+6.9%−4.9%
2022−2.1%+2.6%−4.7%
2021+25.9%+18.3%+7.6%
2020+13.3%+5.2%+8.1%
2019+20.7%+19.1%+1.5%
2018+6.3%−5.7%+12.0%
2017+21.7%+15.4%+6.3%
2016−2.8%−17.8%+14.9%

Source: Fund prospectus bar charts

Holdings overlap

8 of XLV's top 25 holdings also appear in PPH's top 25.

Shared top holdings
HoldingXLVPPH
Eli Lilly & Co16.51%20.23%
Johnson & Johnson10.64%4.35%
AbbVie Inc7.74%4.57%
Merck & Co Inc5.52%9.85%
Pfizer Inc2.39%4.51%
Bristol-Myers Squibb Co2.05%4.47%
McKesson Corp1.58%4.12%
Cencora Inc0.96%3.36%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

PPH top 10

  1. Eli Lilly & Co — 20.23%
  2. Novartis AG — 10.63%
  3. Merck & Co Inc — 9.85%
  4. Novo Nordisk A/S — 5.37%
  5. AbbVie Inc — 4.57%
  6. Pfizer Inc — 4.51%
  7. Bristol-Myers Squibb Co — 4.47%
  8. Gsk Plc — 4.42%
  9. Johnson & Johnson — 4.35%
  10. AstraZeneca PLC — 4.33%

FAQ

What is the difference between XLV and PPH?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PPH (VanEck Pharmaceutical ETF) share a meaningful slice of their top holdings — about 43% by weight. But XLV is far broader, holding 65 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
Which is cheaper, XLV or PPH?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and PPH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.